HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.

AbstractBACKGROUND:
Associations between vaccinations, particularly hepatitis B, and onset of rheumatoid arthritis (RA) have been reported, but examined in few large-scale studies.
METHOD:
Onset of RA cases and dates of vaccination against hepatitis B, tetanus, and influenza were identified in a retrospective chart review of approximately 1 million Kaiser Permanente Northern California members ages 15-59 years from 1997 through 1999. In a cohort analysis, rates of new-onset RA were compared between vaccinated and unvaccinated within 90, 180, and 365 days. In a case-control analysis, rates of vaccination during exposure intervals (90, 180, 365, and 730 days) were compared between cases and controls using conditional logistic regression.
RESULTS:
378 RA cases were included in the cohort analysis; 37 additional cases were included in the case-control analysis. In the cohort analysis the relative risks of RA onset within 90, 180, or 365 days of hepatitis B vaccination were not significant (R.R.=1.44, p=0.53; R.R.=1.67, p=0.22; R.R.=1.23, p=0.59 respectively). We found a possible association between RA and influenza vaccine in the previous 180 and 365 days in the cohort analysis (R.R=1.36, p=0.03; R.R.=1.34, p=0.01 respectively), but in the case-control analysis, cases were no more likely than controls to have received any of the three vaccines.
CONCLUSIONS:
In this large retrospective study we found no statistically significant association between exposure to hepatitis B vaccine and onset of RA. A possible association between RA and influenza vaccination in the cohort study was not borne out in the larger case-control analysis.
AuthorsPaula Ray, Steven Black, Henry Shinefield, Aileen Dillon, Diane Carpenter, Edwin Lewis, Pat Ross, Robert T Chen, Nicola P Klein, Roger Baxter, Vaccine Safety Datalink Team
JournalVaccine (Vaccine) Vol. 29 Issue 38 Pg. 6592-7 (Sep 02 2011) ISSN: 1873-2518 [Electronic] Netherlands
PMID21763385 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Hepatitis B Vaccines
  • Influenza Vaccines
  • Tetanus Toxoid
Topics
  • Adolescent
  • Adult
  • Arthritis, Rheumatoid (chemically induced, epidemiology)
  • California (epidemiology)
  • Case-Control Studies
  • Female
  • Hepatitis B Vaccines (administration & dosage, adverse effects)
  • Humans
  • Influenza Vaccines (administration & dosage, adverse effects)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment
  • Tetanus Toxoid (administration & dosage, adverse effects)
  • Vaccination (adverse effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: